ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,002.80
      0.00%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.735
      0.19%
      Bitcoin
      66,618.59
      0.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Centogene NV (CNTG)

      7. Centogene NV (CNTG) News

      CNTG Centogene NV

      0.48
      0.00 (0.00%)
      Apr 23 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Centogene NV CNTG NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.48 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      0.48
      more quote information »

      Recent News

      Date Time Source Heading
      4/02/202416:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
      3/19/202406:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
      2/29/202417:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/29/202417:00GLOBECENTOGENE Collaborates on Research Published in Science..
      2/28/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/28/202406:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
      2/28/202406:30GLOBECENTOGENE Explores Strategic Alternatives
      2/28/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/25/202406:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
      1/25/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/24/202406:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
      1/24/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/23/202406:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/23/202406:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
      1/18/202407:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/18/202406:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
      12/19/202307:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/19/202306:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
      12/18/202306:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/13/202306:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/13/202306:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
      12/01/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/28/202306:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
      11/28/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/14/202308:30GLOBECENTOGENE, University College London, and Global Team of..
      11/03/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/27/202307:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/10/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/10/202306:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
      10/06/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/11/202308:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
      9/07/202317:00GLOBECENTOGENE Reports First Half 2023 Financial Results
      9/07/202317:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/01/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/01/202308:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
      8/31/202316:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
      8/31/202316:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/18/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/07/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
      7/14/202306:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/14/202306:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
      7/12/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/12/202307:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
      7/02/202305:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
      6/30/202316:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/30/202316:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
      6/27/202307:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..
      6/14/202316:30GLOBECENTOGENE Receives Nasdaq Notification Regarding Minimum..
      5/16/202318:25GLOBECENTOGENE Reports Full Year 2022 Financial Results
      5/05/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in May

      Your Recent History

      NASDAQ
      CNTG
      Centogene NV
      Delayed Upgrade Clock